Preclinical News and Research

RSS
Study uncovers how the body's bile acids bind to block C. diff's most dangerous toxin

Study uncovers how the body's bile acids bind to block C. diff's most dangerous toxin

New antibody shows ability to overcome treatment resistance in blood cancers and solid tumors

New antibody shows ability to overcome treatment resistance in blood cancers and solid tumors

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis

Early RSV infection turns maternal allergy into a powerful driver of childhood asthma

Early RSV infection turns maternal allergy into a powerful driver of childhood asthma

Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root cause

Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root cause

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

First new fibromyalgia drug in 15 years, Tonmya (cyclobenzaprine HCl) gains FDA approval and hits pharmacy shelves

First new fibromyalgia drug in 15 years, Tonmya (cyclobenzaprine HCl) gains FDA approval and hits pharmacy shelves

Ripple & Bausch’s licensing agreement: What it means in ocular delivery

Ripple & Bausch’s licensing agreement: What it means in ocular delivery

Engineered herpes virus activates potent immune responses against glioblastoma

Engineered herpes virus activates potent immune responses against glioblastoma

Study shows glial cells actively shape addictive responses to nicotine

Study shows glial cells actively shape addictive responses to nicotine

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity

Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity

Common water pill may be a useful add‑on to the standard HIV treatment

Common water pill may be a useful add‑on to the standard HIV treatment

Generative AI aids discovery of ISM3830's novel scaffold

Generative AI aids discovery of ISM3830's novel scaffold

Circadian rhythms can influence outcomes related to influenza infections

Circadian rhythms can influence outcomes related to influenza infections

New consortium aims to fast-track breakthroughs against follicular lymphoma

New consortium aims to fast-track breakthroughs against follicular lymphoma

Automated production of lung organoids could revolutionize the development of treatments

Automated production of lung organoids could revolutionize the development of treatments

Semaglutide helps older adults lose weight without immediate bone loss

Semaglutide helps older adults lose weight without immediate bone loss

How the gut microbiome links obesity to colorectal cancer

How the gut microbiome links obesity to colorectal cancer

Study demonstrates a safer strategy for allogeneic stem cell transplants

Study demonstrates a safer strategy for allogeneic stem cell transplants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.